Andere Sprachen Cresco Labs Inc.

Aktien

A2PAHM

CA22587M1068

CL

Markt geschlossen - Canadian Securities Exchange Andere Börsenplätze 21:53:16 05.06.2024			% 5 Tage	% 1. Jan.
2,45 ^CAD	-0,41 %		-1,21 %	+36,87 %

16.05.	Cresco Labs Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
15.05.	Transcript : Cresco Labs Inc., Q1 2024 Earnings Call, May 15, 2024

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Cresco Labs Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	16.05.
Cresco Labs : UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS AS OF AND FOR THE THREE MONTHS ENDED - Form 6-K	16.05.
Earnings Flash (CL) CRESCO LABS Posts Q1 Revenue $184.3M	15.05.
Cresco Labs Reports Continued Trend of Financial Improvement with First Quarter 2024 Financial Results	15.05.
Cresco Labs Inc. (CNSX:CL) acquired Two medical dispensaries in Pennsylvania of Keystone Integrated Care, LLC for $9.8 million.	15.05.
Cresco Labs Announces May Conference Participation	09.05.
Canadian Investment Regulatory Organization Trading Halt - CL	30.04.
Canadian Investment Regulatory Organization Trade Resumption - CL	30.04.
Cresco Labs to Report First Quarter 2024 Financial Results on May 15, 2024	30.04.
Jushi Holdings Inc. Brief: Appointed Todd West as Chief Operating Officer, Effective April 12, 2024; Most Recent Role Was As Executive Vice President of Operations at Cresco Labs Inc	15.04.
Cresco Labs Reports Fourth Quarter and Full Year 2023 Financial Results Demonstrating Significant Profitability and Cash Flow Improvements	14.03.
Cresco Labs Swings to Profit in Q4, Revenue Drops; Up 10.4%	13.03.
Cresco Labs Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13.03.
Cresco Labs Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13.03.
Cresco Labs Inc. Provides Revenue Guidance for the First Quarter of 2024	13.03.
Cresco Labs Swings to Profit in Q4, Revenue Drops	13.03.
Cresco Labs Brief: Fourth quarter revenue of US$188 million; net income of $5 million.	13.03.
Cresco Labs Reports Fourth Quarter & Full Year 2023 Financial Results Demonstrating Significant Profitability and Cash Flow Improvements	13.03.
Agrify Corp Stock Presents Compelling Opportunity As Deal Flow Intensifies ($AGFY)	07.03.
Cresco Labs to Report Fourth Quarter and Annual 2023 Financial Results on March 13, 2024	27.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Cresco Labs Inc.

Aktien

A2PAHM

CA22587M1068

CL

Andere Sprachen

Filter